Improving PTSD Treatment for People in Substance Use Care
Hybrid Effectiveness-Implementation Trial of Massed PTSD Treatment in a Community Substance Use Program
This research aims to make a proven PTSD treatment more accessible and effective for individuals also receiving care for substance use.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers, the State Univ of N.j. NIH-funded |
| Lab location | 1 site (Piscataway, United States) |
| Project ID | NIH-11181643 on NIH RePORTER |
What this research studies
Many people experience both post-traumatic stress disorder (PTSD) and substance use disorder (SUD), and treating both at the same time is very important. While a treatment called Prolonged Exposure (PE) is known to help with PTSD, it's often hard for people with SUD to access or complete it. This project will explore offering PE in a 'massed' format, meaning multiple sessions per week, within intensive outpatient substance use programs. The goal is to see if this approach can help more people attend and benefit from PTSD treatment, leading to better overall recovery.
Who could benefit from this research
Good fit: Ideal candidates would be individuals experiencing both PTSD and substance use disorder who are currently participating in or seeking intensive outpatient substance use treatment.
Not a fit: Patients who do not have co-occurring PTSD and substance use disorder, or who are not interested in a massed treatment format, may not find this particular approach beneficial.
Why it matters
Potential benefit: If successful, this approach could significantly improve how PTSD is treated for individuals also managing substance use, potentially leading to better mental health and recovery outcomes.
How similar studies have performed: Prolonged Exposure (PE) is a well-established and effective treatment for PTSD, and massed PE has shown promise in improving attendance and outcomes compared to weekly sessions.
Where this research is happening
Piscataway, United States
- Rutgers, the State Univ of N.j. — Piscataway, United States (Active)
Researchers
- Principal investigator: Hien, Denise Aimee — Rutgers, the State Univ of N.j.
- Study coordinator: Hien, Denise Aimee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.